Introduction to CGM Technology

Continuous Glucose Monitoring (CGM) has transformed diabetes management over the past decade. Unlike traditional fingerstick methods that provide a single glucose reading at a point in time, CGM systems deliver real-time glucose data every few minutes, giving users and healthcare providers a complete picture of glucose trends and patterns.

For healthcare brands looking to enter the diabetes management market, understanding the core technology behind CGM systems is essential.

CGM sensor technology and digital health interface illustration

How CGM Sensors Work

Modern CGM systems use a thin, flexible sensor filament inserted just beneath the skin to measure glucose levels in the interstitial fluid. The sensor contains a glucose oxidase enzyme that reacts with glucose molecules, creating an electrical signal proportional to the glucose concentration.

Key components of a CGM system include:

MARD: The Accuracy Standard

MARD (Mean Absolute Relative Difference) is the primary metric used to evaluate CGM accuracy. It measures the average difference between CGM readings and reference blood glucose values:

EverChek achieves MARD values below 8%, among the most accurate CGM systems available for B2B partnerships.

Key Features Healthcare Brands Should Look For

The Growing CGM Market

The global CGM market is projected to reach $16 billion by 2028. For healthcare brands, this represents a significant opportunity. By partnering with an experienced manufacturer like EverChek, businesses can bring branded CGM products to market faster with lower upfront investment.